Pay in 4 interest-free payments of $5.92 Learn more
Ships within 48 hours · Estimated delivery Aug 26 - Aug 31
Coverage also varies by plan
Although early studies were unclear (92), more recent studies with Western blotting, immunolocalization, and PCR have shown the presence of GLP-1R in acinar and in some cases duct cells (54, 128)
Clinical guidelines support the use of these medications for patients with obesity or type 2 diabetes when lifestyle modifications alone are insufficient
Tirzepatide's once-weekly dosing schedule and extended half-life of approximately 5 days help maintain consistent therapeutic levels regardless of injection site
Diabetes Care 21 October 2024
The compound is the same synthetic triple receptor agonist at GIPR, GLP-1R and GCGR across every vial size, molecular formula CHNO, molecular weight 4731.3 g/mol, CAS 2381089-83-2
US$ 21.95
US$ 29.97
US$ 27.41
US$ 26.37
US$ 22.00
US$ 26.69
US$ 22.85
